205 related articles for article (PubMed ID: 6093595)
1. Nitrendipine: effects on vascular responses and myocardial binding.
McBride W; Mukherjee A; Haghani Z; Wheeler-Clark E; Brady J; Gandler T; Bush L; Buja LM; Willerson JT
Am J Physiol; 1984 Nov; 247(5 Pt 2):H775-83. PubMed ID: 6093595
[TBL] [Abstract][Full Text] [Related]
2. Binding of a calcium antagonist, [3H]nitrendipine, to high affinity sites in bovine aortic smooth muscle and canine cardiac membranes.
Williams LT; Tremble P
J Clin Invest; 1982 Jul; 70(1):209-12. PubMed ID: 6282938
[TBL] [Abstract][Full Text] [Related]
3. Binding of the calcium channel blocker nitrendipine to its receptor in purified sarcolemma from canine cardiac ventricle.
Sarmiento JG; Janis RA; Colvin RA; Triggle DJ; Katz AM
J Mol Cell Cardiol; 1983 Feb; 15(2):135-7. PubMed ID: 6304327
[TBL] [Abstract][Full Text] [Related]
4. Comparison of high affinity binding of calcium channel blocking drugs to vascular smooth muscle and cardiac sarcolemmal membranes.
Sarmiento JG; Janis RA; Katz AM; Triggle DJ
Biochem Pharmacol; 1984 Oct; 33(20):3119-23. PubMed ID: 6487362
[TBL] [Abstract][Full Text] [Related]
5. Effects of a new dihydropyridine calcium antagonist on vascular smooth muscles, cardiac muscles and [3H]-nitrendipine binding.
Miura A; Ukai Y; Matsuzaki T; Taniguchi N; Hayashi S; Kano S; Kimura Y; Kimura K; Enomoto H
Arzneimittelforschung; 1986 Sep; 36(9):1323-8. PubMed ID: 3790181
[TBL] [Abstract][Full Text] [Related]
6. Calcium-channel antagonist binding to isolated vascular smooth muscle membranes.
Triggle CR; Agrawal DK; Bolger GT; Daniel EE; Kwan CY; Luchowski EM; Triggle DJ
Can J Physiol Pharmacol; 1982 Dec; 60(12):1738-41. PubMed ID: 7165866
[TBL] [Abstract][Full Text] [Related]
7. Nitrendipine block of cardiac calcium channels: high-affinity binding to the inactivated state.
Bean BP
Proc Natl Acad Sci U S A; 1984 Oct; 81(20):6388-92. PubMed ID: 6093100
[TBL] [Abstract][Full Text] [Related]
8. Relationship of binding of a calcium channel blocker to inhibition of contraction in intact cultured embryonic chick ventricular cells.
Marsh JD; Loh E; Lachance D; Barry WH; Smith TW
Circ Res; 1983 Oct; 53(4):539-43. PubMed ID: 6313249
[TBL] [Abstract][Full Text] [Related]
9. A calcium antagonist drug binding site in skeletal muscle sarcoplasmic reticulum: evidence for a calcium channel.
Fairhurst AS; Thayer SA; Colker JE; Beatty DA
Life Sci; 1983 Mar; 32(12):1331-9. PubMed ID: 6300579
[TBL] [Abstract][Full Text] [Related]
10. Tissue response selectivity of calcium antagonists is not due to heterogeneity of [3H]-nitrendipine binding sites.
Bristow MR; Ginsburg R; Laser JA; McAuley BJ; Minobe W
Br J Pharmacol; 1984 Jun; 82(2):309-20. PubMed ID: 6329392
[TBL] [Abstract][Full Text] [Related]
11. Effects of Bay k 8644, a dihydropyridine analog, on [3H]nitrendipine binding to canine cardiac sarcolemma and the relationship to a positive inotropic effect.
Vaghy PL; Grupp IL; Grupp G; Schwartz A
Circ Res; 1984 Oct; 55(4):549-53. PubMed ID: 6206963
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of the binding of [3H]nitrendipine to rabbit ventricular membranes: modification by other Ca++ channel antagonists and by the Ca++ channel agonist Bay K 8644.
Janis RA; Sarmiento JG; Maurer SC; Bolger GT; Triggle DJ
J Pharmacol Exp Ther; 1984 Oct; 231(1):8-15. PubMed ID: 6208356
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of receptor sites for [3H]nitrendipine in chick hearts and physiological relation to the slow Ca2+ channel and to excitation-contraction coupling.
Renaud JF; Kazazoglou T; Schmid A; Romey G; Lazdunski M
Eur J Biochem; 1984 Mar; 139(3):673-81. PubMed ID: 6321185
[TBL] [Abstract][Full Text] [Related]
14. Characterization of binding of the Ca++ channel antagonist, [3H]nitrendipine, to guinea-pig ileal smooth muscle.
Bolger GT; Gengo P; Klockowski R; Luchowski E; Siegel H; Janis RA; Triggle AM; Triggle DJ
J Pharmacol Exp Ther; 1983 May; 225(2):291-309. PubMed ID: 6842393
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
[TBL] [Abstract][Full Text] [Related]
16. Calcium antagonistic effects and the in vitro duration of actions of KW-3049, a new 1,4-dihydropyridine derivative, in isolated canine coronary arteries.
Karasawa A; Kubo K
Jpn J Pharmacol; 1988 May; 47(1):35-44. PubMed ID: 3411819
[TBL] [Abstract][Full Text] [Related]
17. High affinity binding sites for [3H]-nitrendipine in rabbit uterine smooth muscle.
Miller WC; Moore JB
Life Sci; 1984 Apr; 34(18):1717-24. PubMed ID: 6727544
[TBL] [Abstract][Full Text] [Related]
18. Direct photoaffinity labeling of the high affinity nitrendipine-binding site in subcellular membrane fractions isolated from canine myocardium.
Campbell KP; Lipshutz GM; Denney GH
J Biol Chem; 1984 May; 259(9):5384-7. PubMed ID: 6325434
[TBL] [Abstract][Full Text] [Related]
19. Ca2+ channel antagonist actions in bladder smooth muscle: comparative pharmacologic and [3H]nitrendipine binding studies.
Yousif FB; Bolger GT; Ruzycky A; Triggle DJ
Can J Physiol Pharmacol; 1985 May; 63(5):453-62. PubMed ID: 2994869
[TBL] [Abstract][Full Text] [Related]
20. [3H]-Nitrendipine, a potent calcium antagonist, binds with high affinity to cardiac membranes.
Bellemann P; Ferry D; Lübbecke F; Glossman H
Arzneimittelforschung; 1981; 31(12):2064-7. PubMed ID: 7199299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
